Drug Elimination: Non-Renal Routes

Hepatocytes in the liver secrete bile containing active transporters that discharge polar drugs and hydrophilic drug metabolites. The bile carries these substances into the small intestine, where they are eventually eliminated through feces. This process is a primary non-renal route for drug elimination and helps reduce systemic drug levels.

Enterohepatic circulation occurs when drugs or metabolites are reabsorbed from the intestine and transported back to the liver for re-secretion via bile. This recycling prolongs drug action but increases toxicity risk. Understanding this cycle is important for predicting drug duration and managing potential adverse effects in patients.

Anesthetic gases are primarily eliminated through the lungs via exhalation. Lipophilic and nonionized drugs are excreted through saliva by diffusing across epithelial cells of the salivary gland. These routes represent alternative elimination pathways when renal and hepatic clearance are insufficient or when drug properties favor pulmonary or salivary excretion.

Drugs excreted through breast milk can transfer to suckling infants, causing undesirable or harmful effects. Nursing mothers taking certain medications may expose their infants to drug exposure during a critical developmental period. Healthcare providers must evaluate drug safety profiles and consider alternatives when prescribing to lactating women.

Gut microflora hydrolyze drug metabolites in the intestine, regenerating parent drugs that may be reabsorbed and returned to the liver. This microbial metabolism can influence drug bioavailability and enterohepatic circulation patterns. Antibiotic use disrupting normal microflora can alter expected drug elimination and therapeutic outcomes.

Active transporters in hepatocyte membranes actively discharge polar and hydrophilic drugs into bile against concentration gradients. These carrier-mediated processes require energy and are selective for specific drug structures. Transporter function directly determines biliary clearance rates and influences overall drug elimination when renal routes are compromised.

Drug lipophilicity and ionization determine excretion pathways. Lipophilic, nonionized drugs readily diffuse through salivary gland epithelium and are excreted in saliva. Polar and hydrophilic drugs require active transporters for biliary excretion. These physicochemical properties predict which non-renal elimination route predominates and influence factors influencing bioavailability.